Processing

Please wait...

Settings

Settings

1. WO2009139708 - PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST

Publication Number WO/2009/139708
Publication Date 19.11.2009
International Application No. PCT/SE2009/050525
International Filing Date 12.05.2009
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
439
the ring forming part of a bridged ring system, e.g. quinuclidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
06
Antiasthmatics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
08
Bronchodilators
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
428
condensed with carbocyclic rings
A61K 31/439 (2006.01)
A61P 11/06 (2006.01)
A61P 11/08 (2006.01)
A61K 31/428 (2006.01)
CPC
A61K 31/428
A61K 31/439
A61K 45/06
Applicants
  • ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje, SE (AllExceptUS)
  • PULMAGEN THERAPEUTICS (SYNERGY) LIMITED [GB/GB]; Fulmer Hall, Windmill Road Fulmer, Slough, SL3 6HD, GB (AllExceptUS)
  • BULL, Richard, James [GB/GB]; GB (UsOnly)
  • FORD, Rhonan [GB/GB]; GB (UsOnly)
  • MATHER, Andrew [GB/GB]; GB (UsOnly)
  • METE, Antonio [IT/GB]; GB (UsOnly)
  • WILEY, Katherine [GB/GB]; GB (UsOnly)
Inventors
  • BULL, Richard, James; GB
  • FORD, Rhonan; GB
  • MATHER, Andrew; GB
  • METE, Antonio; GB
  • WILEY, Katherine; GB
Agents
  • ASTRAZENECA AB; AstraZeneca Intellectual Property S-151 85 Södertälje, SE
Priority Data
0808710.813.05.2008GB
0900563.814.01.2009GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
(FR) PRODUIT PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET UN AGONISTE DES β2-ADRÉNOCEPTEURS
Abstract
(EN)
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is a β2-adrenoceptor agonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
(FR)
L'invention concerne un produit pharmaceutique, un kit ou une composition comprenant un premier principe actif qui est un antagoniste du récepteur muscarinique sélectionné, et un deuxième principe actif qui est un agoniste des β2-adrénocepteurs, à utiliser dans le traitement de maladies respiratoires de type maladie pulmonaire obstructive chronique et asthme.
Latest bibliographic data on file with the International Bureau